Business Standard

Sunday, January 05, 2025 | 03:47 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Neuland Laboratories successfully completes USFDA inspection of Pashmylaram unit

Image

Capital Market

With zero observations under Form 483

Neuland Laboratories announced that USFDA inspected one of the Manufacturing facilities of the Company (Unit 2), located at Pashmylaram, Patancheru Mandal, Sangareddy District, from 26 to 29 of November, 2018.

The inspection at Unit 2 by the US FDA has been successfully completed, with no observations under Form 483.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 29 2018 | 2:32 PM IST

Explore News